J. Segura

18.6k total citations · 2 hit papers
236 papers, 4.8k citations indexed

About

J. Segura is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, J. Segura has authored 236 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Cardiology and Cardiovascular Medicine, 58 papers in Endocrinology, Diabetes and Metabolism and 47 papers in Surgery. Recurrent topics in J. Segura's work include Blood Pressure and Hypertension Studies (177 papers), Heart Rate Variability and Autonomic Control (49 papers) and Hormonal Regulation and Hypertension (41 papers). J. Segura is often cited by papers focused on Blood Pressure and Hypertension Studies (177 papers), Heart Rate Variability and Autonomic Control (49 papers) and Hormonal Regulation and Hypertension (41 papers). J. Segura collaborates with scholars based in Spain, United States and United Kingdom. J. Segura's co-authors include Luís M. Ruilope, Manuel Gorostidi, José R. Banegas, Alejandro de la Sierra, Juan J. de la Cruz, Ernest Vinyoles, Carlos Campo, Anna Oliveras, Pedro Armario and Gema Ruiz‐Hurtado and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

J. Segura

211 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

2011 535 citations Alejandro de la Sierra, J. Segura et al. Hypertension profile →
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

2023 139 citations Natalie Staplin, Alejandro de la Sierra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Segura Spain	37	3.5k	924	859	783	777	236	4.8k
Isla S. Mackenzie United Kingdom	31	2.2k 0.6×	961 1.0×	799 0.9×	356 0.5×	426 0.5×	93	4.3k
Alejandro de la Sierra Spain	39	4.2k 1.2×	1.1k 1.2×	931 1.1×	283 0.4×	1.2k 1.5×	230	5.8k
Vito M. Campese United States	35	2.4k 0.7×	950 1.0×	803 0.9×	1.1k 1.4×	688 0.9×	119	4.6k
José L. Rodicio Spain	33	3.9k 1.1×	1.3k 1.5×	1.0k 1.2×	1.1k 1.5×	818 1.1×	138	6.2k
David Conen Switzerland	40	4.2k 1.2×	865 0.9×	795 0.9×	345 0.4×	327 0.4×	238	6.3k
Gastone Leonetti Italy	39	5.5k 1.6×	1.8k 1.9×	935 1.1×	510 0.7×	840 1.1×	197	7.0k
Mátyás Keltai Hungary	30	5.3k 1.5×	1.5k 1.6×	1.8k 2.0×	546 0.7×	352 0.5×	71	7.0k
Agustín J. Ramiréz Argentina	20	2.4k 0.7×	656 0.7×	503 0.6×	262 0.3×	488 0.6×	84	4.1k
Harry A. Struijker Boudier Netherlands	12	4.7k 1.3×	1.3k 1.4×	952 1.1×	332 0.4×	605 0.8×	12	5.9k
Ole Lederballe‐Pedersen United States	16	5.4k 1.5×	2.7k 3.0×	811 0.9×	857 1.1×	694 0.9×	23	6.8k

Countries citing papers authored by J. Segura

Since Specialization

Citations

This map shows the geographic impact of J. Segura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Segura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Segura more than expected).

Fields of papers citing papers by J. Segura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Segura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Segura. The network helps show where J. Segura may publish in the future.

Co-authorship network of co-authors of J. Segura

This figure shows the co-authorship network connecting the top 25 collaborators of J. Segura. A scholar is included among the top collaborators of J. Segura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Segura. J. Segura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González‐Lafuente, Laura, Lisardo Boscá, María Fernández‐Velasco, et al.. (2024). Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation. Nefrología (English Edition). 44(6). 818–829. 4 indexed citations

Böhm, Michael, Alejandro de la Sierra, Felix Mahfoud, et al.. (2024). Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes. European Heart Journal. 45(31). 2851–2861. 3 indexed citations

Sierra, Alejandro de la, Luís M. Ruilope, Natalie Staplin, et al.. (2024). Resistant Hypertension and Mortality: An Observational Cohort Study. Hypertension. 81(11). 2350–2356. 7 indexed citations

Martin‐Lorenzo, Marta, María Gómez‐Serrano, Juan Antonio López, et al.. (2024). The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease. International Journal of Molecular Sciences. 25(13). 7005–7005. 2 indexed citations

Guimarães, Pedro, Andreas Keller, Michael Böhm, et al.. (2024). Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure. Hypertension. 82(1). 46–56.

Sierra, Alejandro de la, Bryan Williams, Michael Bursztyn, et al.. (2024). Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM Registry. Hypertension. 81(5). 1125–1131. 3 indexed citations

Vinyoles, Ernest, Albert Roso‐Llorach, Alejandro de la Sierra, et al.. (2022). Role of ambulatory blood pressure on prediction of cardiovascular disease. A cohort study. Journal of Human Hypertension. 37(4). 279–285. 7 indexed citations

Rodríguez‐Sánchez, Elena, José Alberto Navarro‐García, Teresa Bada-Bosch, et al.. (2020). Variations in Circulating Active MMP-9 Levels during Renal Replacement Therapy. Biomolecules. 10(4). 505–505. 6 indexed citations

Rodríguez‐Sánchez, Elena, José Alberto Navarro‐García, Gloria Álvarez‐Llamas, et al.. (2018). Asociación entre disminución de la función renal y actividad metaloproteinasa-9 en el paciente hipertenso. Nefrología. 39(2). 184–191. 11 indexed citations

10.

Segura, J., et al.. (2013). Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition. Expert Opinion on Investigational Drugs. 22(7). 915–925. 22 indexed citations

11.

Sierra, Alejandro de la, J. Segura, José R. Banegas, et al.. (2011). Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring. Hypertension. 57(5). 898–902. 535 indexed citations breakdown →

12.

Segura, J. & Luís M. Ruilope. (2011). Hypertension in Moderate-to-Severe Nondiabetic CKD Patients. Advances in Chronic Kidney Disease. 18(1). 23–27. 18 indexed citations

13.

Segura, J., et al.. (2010). TRENDS IN ALBUMINURIA UNDER RENIN-ANGIOTENSIN SYSTEM SUPPRESSION. Journal of Hypertension. 28. 3 indexed citations

14.

Morales, Enrique, et al.. (2009). Efecto antiproteinúrico del bloqueo del sistema renina-angiotensina-aldosterona (SRAA) en los pacientes obesos: ¿Cuál es la opción terapéutica más eficaz?. Nefrología. 29(5). 421–429. 8 indexed citations

15.

Barrios, Vivencio, Carlos Escobar, Mariano de la Figuera, et al.. (2008). Tolerability of High Doses of Lercanidipine versus High Doses of Other Dihydropyridines in Daily Clinical Practice: The TOLERANCE Study. Cardiovascular Drug Reviews. 26(1). 2–9. 10 indexed citations

16.

Marin, Raúl, Manuel Gorostidi, Aleix Cases, et al.. (2006). Guía de la Sociedad Española de Nefrología sobre riñón y enfermedad cardiovascular.: Versión Abreviada. Nefrología. 26(1). 31–44. 8 indexed citations

17.

Ruilope, Luís M. & J. Segura. (2006). Renal protection in diabetic patients: benefits of a first-line combination of perindopril–indapamide (Preterax®). Journal of Hypertension. 24(Suppl 3). S9–S12. 1 indexed citations

18.

Segura, J., Carlos Campo, & Luís M. Ruilope. (2004). Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney International. 66(92). S45–S49. 32 indexed citations

19.

Ruilope, Luís M., Vivencio Barrios, J. Segura, & Carlos Campo. (1999). The kidney in heart failure: role of angiotensin II. Current Opinion in Nephrology & Hypertension. 8(2). 153–156. 3 indexed citations

20.

Moreno, María, F Castellanos, Juan Carlos Herrero, et al.. (1998). Influence of Hepatitis C Virus Infection on FK 506 Blood Levels in Renal Transplant Patients. Transplantation Proceedings. 30(4). 1264–1265. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact